Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 10;21(14):4886.
doi: 10.3390/ijms21144886.

The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis

Affiliations
Review

The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis

Nai-Yu Ko et al. Int J Mol Sci. .

Abstract

Osteoporosis is a major concern worldwide and can be attributed to an imbalance between osteoblastic bone formation and osteoclastic bone resorption due to the natural aging process. Heritable factors account for 60-80% of optimal bone mineralization; however, the finer details of pathogenesis remain to be elucidated. Micro RNA (miRNA) and long-non-coding RNA (lncRNA) are two targets that have recently come into the spotlight due to their ability to control gene expression at the post-transcriptional level and provide epigenetic modification. miRNAs are a class of non-coding RNAs that are approximately 18-25 nucleotides long. It is thought that up to 60% of human protein-coding genes may be regulated by miRNAs. They have been found to regulate gene expression that controls osteoblast-dependent bone formation and osteoclast-related bone remodeling. lncRNAs are highly structured RNA transcripts longer than 200 nucleotides that do not translate into proteins. They have very complex secondary and tertiary structures and the same degradation processes as messenger RNAs. The fact that they have a rapid turnover is due to their sponge function in binding the miRNAs that lead to a degradation of the lncRNA itself. They can act as signaling, decoy, and framework molecules, or as primers. Current evidence suggests that lncRNAs can act as chromatin and transcriptional as well as post-transcriptional regulators. With regards to osteoporosis, lncRNA is thought to be involved in the proliferation, apoptosis, and inflammatory response of the bone. This review, which is based on a systematic appraisal of the current literature, provides current molecular and genetic opinions on the roles of miRNAs and lncRNAs in osteoporosis. Further research into the epigenetic modification and the regulatory roles of these molecules will bring us closer to potential disease-modifying treatment for osteoporosis. However, more issues regarding the detailed actions of miRNAs and lncRNAs in osteoporosis remain unknown and controversial and warrant future investigation.

Keywords: lncRNA; long-non-coding RNA; miRNA; micro RNA; osteoporosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Diagram of the biosynthesis and function of long-non-coding RNAs (lncRNAs). lncRNAs are derived from genes, some containing introns and some containing exons. These lncRNAs then act as signaling (for gene activation), decoy (for gene suppression), or scaffold molecules to exert epigenetic modification.

References

    1. Tang P., Xiong Q., Ge W., Zhang L. The Role of MicroRNAs in Osteoclasts and Osteoporosis. RNA Biol. 2014;11:1355–1363. doi: 10.1080/15476286.2014.996462. - DOI - PMC - PubMed
    1. Feng Q., Zheng S., Zheng J. The Emerging Role of MicroRNAs in Bone Remodeling and Its Therapeutic Implications for Osteoporosis. Biosci. Rep. 2018;38 doi: 10.1042/BSR20180453. - DOI - PMC - PubMed
    1. van Wijnen A., van de Peppel J., van Leeuwen J., Lian J., Stein G., Westendorf J., Oursler M., Im H.J., Taipaleenmäki H., Hesse E., et al. MicroRNA Functions in Osteogenesis and Dysfunctions in Osteoporosis. Cur. Osteoporos. Rep. 2013;2:72–82. doi: 10.1007/s11914-013-0143-6. - DOI - PMC - PubMed
    1. Ge D., Wang W., Chen H., Yang L., Cao X. Functions of MicroRNAs in Osteoporosis. Eur. Rev. Med. and Pharmacol. Sci. 2017;21:4784–4789. - PubMed
    1. Foessl I., Kotzbeck P., Obermayer-Pietsch B. MiRNAs as Novel Biomarkers for Bone Related Diseases. [(accessed on 2 July 2020)];J. Lab. Precis. Med. 2019 4 doi: 10.21037/jlpm.2018.12.06. Available online: http://jlpm.amegroups.com/article/view/4655. - DOI